TARGETED THERAPY FOR HEMATOLOGICAL MALIGNANCIES
Mona Shafik Mahmoud El Ashry;
Abstract
Leukemias and lymphomas are relatively common, affect all ages and demonstrate extra-ordinary biologic, morphologic and clinical heterogenecity. Immunotherapy, mainly antibody-based therapy in non-Hodgkin’s lymphomas, has become one of the success stories
Other data
| Title | TARGETED THERAPY FOR HEMATOLOGICAL MALIGNANCIES | Authors | Mona Shafik Mahmoud El Ashry | Keywords | TARGETED THERAPY FOR HEMATOLOGICAL MALIGNANCIES | Issue Date | 2008 | Description | Leukemias and lymphomas are relatively common, affect all ages and demonstrate extra-ordinary biologic, morphologic and clinical heterogenecity. Immunotherapy, mainly antibody-based therapy in non-Hodgkin’s lymphomas, has become one of the success stories |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 20197Dr. Mona Shafik Mahmoud El Ashry..pdf | 69.88 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.